118 filings
Page 2 of 6
8-K
5uytusma97qutatog2
2 Nov 23
Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
7:41am
8-K
zc7irlhc1sxjboci
12 Sep 23
Other Events
7:00am
8-K
nshxu6s1mrm ocr6vwi
24 Aug 23
Regulation FD Disclosure
7:00am
8-K
6n1549 6kjbksv9zlze
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
424B5
wzm ti3v8
28 Jun 23
Prospectus supplement for primary offering
7:32am
8-K
izwe42pna7vnrmj
28 Jun 23
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
7:27am
8-K
w2onbh4uun9hx49lt1
12 Jun 23
Submission of Matters to a Vote of Security Holders
7:41am
8-K
5rh1e
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
1bf4 s1n2v
1 May 23
Departure of Directors or Certain Officers
7:30am
ARS
effuesplt6j 6su
24 Apr 23
Annual report to shareholders
4:45pm
DEFA14A
8z3hdxps
24 Apr 23
Additional proxy soliciting materials
4:44pm
8-K
nr6iqf4gbjv
19 Apr 23
Developing disease-modifying medicines for degenerative disorders Analyst Breakfast April 2023
7:30am
8-K
nwbsxyhd1rdl2jekk
28 Mar 23
Other Events
7:36am
424B5
fcl4rhk0x
27 Mar 23
Prospectus supplement for primary offering
4:05pm
S-8
eqx c3echa988lovj
23 Mar 23
Registration of securities for employees
4:06pm
8-K
b6fx 2ua59plsqo
23 Mar 23
Cognition Therapeutics Reports Year End 2022 Financial Results and Provides Business Update
7:35am